10-K Filing

BEONE MEDICINES LTD. CIK: 1651308 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001651308-20-000020`
Period End Date	20191231
Filing Date	20200302
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	bgne-2019123110k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 94 Cash Flow Statement 168 Stockholders Equity 36 Comprehensive Income 26

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$712.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$239.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$618.01M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	801.34M	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	776.26M	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.54M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$288.00K	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$1.07B	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$364.73M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	801.34M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$70.88M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$41.06M	USD	Point-in-time
Inventories	`InventoryNet`	$16.24M	USD	Point-in-time
Inventories	`InventoryNet`	$28.55M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$90.24M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$90.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.17B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.94B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.48M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$13.23M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$242.40M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$157.06M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$71.04M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$82.52M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.17M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.85M	USD	Point-in-time
Land use right, net	`LandUseRightNet`	$45.06M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$29.54M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$37.89M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$53.78M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$68.45M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$439.59M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$305.84M	USD	Point-in-time
Total assets	`Assets`	$1.61B	USD	Point-in-time
Total assets	`Assets`	$2.25B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$113.28M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$122.49M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$100.41M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$163.56M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$18.14M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$13.45M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$5.89M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$8.68M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$10.81M	USD	Point-in-time
Long-term bank loans, current portion	`LongTermDebtCurrent`	$8.73M	USD	Point-in-time
Long-term bank loans, current portion	`LongTermDebtCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$246.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$310.31M	USD	Point-in-time
Long-term bank loans, non-current portion	`LongTermDebtNoncurrent`	$83.31M	USD	Point-in-time
Long-term bank loans, non-current portion	`LongTermDebtNoncurrent`	$40.78M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$148.89M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$157.38M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$25.83M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$18.76M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$11.14M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$10.53M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$46.56M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$48.77M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$249.59M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$323.62M	USD	Point-in-time
Total liabilities	`Liabilities`	$633.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$496.04M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, $0.0001 par value per share; 9,500,000,000 shares authorized; 801,340,698 and 776,263,184 shares issued and outstanding as of December 31, 2019 and 2018, respectively	`CommonStockValue`	$77.00K	USD	Point-in-time
Ordinary shares, $0.0001 par value per share; 9,500,000,000 shares authorized; 801,340,698 and 776,263,184 shares issued and outstanding as of December 31, 2019 and 2018, respectively	`CommonStockValue`	$79.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.74B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.93B	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.53M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.96B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$1.74B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$962.21M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$16.15M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$14.45M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$352.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$1.61B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.25B	USD	Point-in-time

Income Statement 94 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$56.89M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$32.54M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$50.14M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$428.21M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$54.20M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$58.67M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$52.80M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$198.22M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$243.35M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$77.83M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$238.39M	USD	Annual
Cost of sales - product	`CostOfGoodsAndServicesSold`	$28.70M	USD	Annual
Cost of sales - product	`CostOfGoodsAndServicesSold`	$4.97M	USD	Annual
Cost of sales - product	`CostOfGoodsAndServicesSold`	$71.19M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$269.02M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$927.34M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$679.00M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$195.38M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$388.25M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$62.60M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$250.00K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$894.00K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.33M	USD	Annual
Total expenses	`CostsAndExpenses`	$903.99M	USD	Annual
Total expenses	`CostsAndExpenses`	$336.84M	USD	Annual
Total expenses	`CostsAndExpenses`	$1.39B	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-151.10M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-85.83M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-959.89M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-173.75M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-705.77M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-388.04M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-312.27M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-163.05M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-280.81M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-98.46M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-110.81M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$9.13M	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$-4.11M	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$13.95M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$7.17M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$11.50M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$1.99M	USD	Annual
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-91.06M	USD	Annual
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-689.83M	USD	Annual
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-943.59M	USD	Annual
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$-15.80M	USD	Annual
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$6.99M	USD	Annual
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$2.23M	USD	Annual
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-144.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-674.03M	USD	Annual
Net loss	`ProfitLoss`	$-387.89M	USD	1 Quarter
Net loss	`ProfitLoss`	$-93.30M	USD	Annual
Net loss	`ProfitLoss`	$-950.58M	USD	Annual
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-266.71M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-194.00K	USD	Annual
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.95M	USD	Annual
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-264.00K	USD	Annual
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-144.03M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-673.77M	USD	Annual
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-104.60M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-948.63M	USD	Annual
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-167.64M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-156.89M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-388.06M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-307.36M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-268.25M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-93.11M	USD	Annual
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-85.57M	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.39	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.17	USD	Annual
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.49	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.22	USD	Annual
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.93	USD	Annual
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	1 Quarter
Weighted-average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	543.19M	shares	Annual
Weighted-average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	720.75M	shares	Annual
Weighted-average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	780.70M	shares	Annual
Net loss per American Depositary Share (ADS), basic and diluted basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-12.15	USD	Annual
Net loss per American Depositary Share (ADS), basic and diluted basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-2.23	USD	Annual
Net loss per American Depositary Share (ADS), basic and diluted basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-15.80	USD	Annual
Weighted-average ADSs outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	55.44M	shares	Annual
Weighted-average ADSs outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	41.78M	shares	Annual
Weighted-average ADSs outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	60.05M	shares	Annual

Cash Flow Statement 168 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-144.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-674.03M	USD	Annual
Net loss	`ProfitLoss`	$-387.89M	USD	1 Quarter
Net loss	`ProfitLoss`	$-93.30M	USD	Annual
Net loss	`ProfitLoss`	$-950.58M	USD	Annual
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-266.71M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$4.76M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$10.39M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$18.62M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$42.86M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$134.15M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$87.13M	USD	Annual
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	-	USD	Annual
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$69.00M	USD	Annual
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$70.00M	USD	Annual
Non-cash interest expense	`InterestExpenseOperatingActivities`	$8.05M	USD	Annual
Non-cash interest expense	`InterestExpenseOperatingActivities`	$7.04M	USD	Annual
Non-cash interest expense	`InterestExpenseOperatingActivities`	$7.82M	USD	Annual
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-21.95M	USD	Annual
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-5.84M	USD	Annual
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-9.23M	USD	Annual
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$41.00K	USD	Annual
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$-9.44M	USD	Annual
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$-9.86M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$29.82M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$11.63M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$29.43M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$10.93M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$5.31M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$12.31M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-45.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$28.88M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$38.61M	USD	Annual
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightofUseAsset`	$11.48M	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$40.23M	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$20.78M	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$29.70M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$55.30M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.22M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$23.47M	USD	Annual
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$50.54M	USD	Annual
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$24.98M	USD	Annual
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$64.03M	USD	Annual
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$7.57M	USD	Annual
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$7.43M	USD	Annual
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-3.35M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-9.06M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$37.04M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-27.98M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$9.20M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$8.48M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$31.39M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$16.96M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-547.72M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-750.27M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.75M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$89.61M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$70.28M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$46.37M	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$553.00K	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Payment for asset acquisition, net of cash acquired	`PaymentForAssetAcquisition`	-	USD	Annual
Payment for asset acquisition, net of cash acquired	`PaymentForAssetAcquisition`	-	USD	Annual
Payment for asset acquisition, net of cash acquired	`PaymentForAssetAcquisition`	$38.30M	USD	Annual
Payment for the acquisition of land use right	`PaymentsforLandUseRight`	-	USD	Annual
Payment for the acquisition of land use right	`PaymentsforLandUseRight`	$12.35M	USD	Annual
Payment for the acquisition of land use right	`PaymentsforLandUseRight`	-	USD	Annual
Cash acquired in business combination, net of cash paid	`CashAcquiredFromAcquisitionNetOfCashPaid`	-	USD	Annual
Cash acquired in business combination, net of cash paid	`CashAcquiredFromAcquisitionNetOfCashPaid`	-	USD	Annual
Cash acquired in business combination, net of cash paid	`CashAcquiredFromAcquisitionNetOfCashPaid`	$19.92M	USD	Annual
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$741.30M	USD	Annual
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$2.64B	USD	Annual
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$1.17B	USD	Annual
Proceeds from sale or maturity of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$423.79M	USD	Annual
Proceeds from sale or maturity of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$2.18B	USD	Annual
Proceeds from sale or maturity of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.88B	USD	Annual
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	-	USD	Annual
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$70.00M	USD	Annual
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$69.00M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-356.32M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-637.61M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$554.16M	USD	Annual
Proceeds from public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	$758.00M	USD	Annual
Proceeds from public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	-	USD	Annual
Proceeds from public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	$189.19M	USD	Annual
Payment of public offering cost	`PaymentsOfStockIssuanceCosts`	$674.00K	USD	Annual
Payment of public offering cost	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Payment of public offering cost	`PaymentsOfStockIssuanceCosts`	$414.00K	USD	Annual
Proceeds from public offering and HK IPO, net of underwriter discount	`ProceedsFromCommonStockIssuanceAndInitialPublicOffering`	-	USD	Annual
Proceeds from public offering and HK IPO, net of underwriter discount	`ProceedsFromCommonStockIssuanceAndInitialPublicOffering`	$875.37M	USD	Annual
Proceeds from public offering and HK IPO, net of underwriter discount	`ProceedsFromCommonStockIssuanceAndInitialPublicOffering`	-	USD	Annual
Payment of public offering and HK IPO costs	`PaymentsOfInitialPublicOfferingCostAndStockIssuanceCost`	-	USD	Annual
Payment of public offering and HK IPO costs	`PaymentsOfInitialPublicOfferingCostAndStockIssuanceCost`	$5.66M	USD	Annual
Payment of public offering and HK IPO costs	`PaymentsOfInitialPublicOfferingCostAndStockIssuanceCost`	-	USD	Annual
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	$149.93M	USD	Annual
Proceeds from long-term bank loans	`ProceedsFromLongTermLinesOfCredit`	$42.31M	USD	Annual
Proceeds from long-term bank loans	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Proceeds from long-term bank loans	`ProceedsFromLongTermLinesOfCredit`	$67.49M	USD	Annual
Repayment of long-term bank loans	`RepaymentsOfLongTermDebt`	$8.74M	USD	Annual
Repayment of long-term bank loans	`RepaymentsOfLongTermDebt`	-	USD	Annual
Repayment of long-term bank loans	`RepaymentsOfLongTermDebt`	$32.81M	USD	Annual
Proceeds from short-term loan	`ProceedsFromShortTermDebt`	$2.47M	USD	Annual
Proceeds from short-term loan	`ProceedsFromShortTermDebt`	-	USD	Annual
Proceeds from short-term loan	`ProceedsFromShortTermDebt`	-	USD	Annual
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	$2.47M	USD	Annual
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	-	USD	Annual
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	-	USD	Annual
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$4.00M	USD	Annual
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$14.53M	USD	Annual
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	Annual
Proceeds from shareholder loan	`ProceedsFromRelatedPartyDebt`	$132.76M	USD	Annual
Proceeds from shareholder loan	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Proceeds from shareholder loan	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$29.66M	USD	Annual
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$4.63M	USD	Annual
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$47.00M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.69B	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$490.36M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$85.68M	USD	Annual
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-9.51M	USD	Annual
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$5.30M	USD	Annual
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-4.10M	USD	Annual
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$152.09M	USD	Annual
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-119.94M	USD	Annual
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$501.11M	USD	Annual
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.77M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.51M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.77M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$87.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$712.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$239.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$618.01M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.54M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$288.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.48M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$13.23M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$12.36M	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$29.29M	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$8.98M	USD	Annual
Interest paid	`InterestPaidNet`	$4.32M	USD	Annual
Interest paid	`InterestPaidNet`	$2.21M	USD	Annual
Interest paid	`InterestPaidNet`	$1.26M	USD	Annual
Discount provided on sale of ordinary shares for business combination	`DiscountProvidedForIssuanceOfOrdinaryShares`	$23.61M	USD	Annual
Discount provided on sale of ordinary shares for business combination	`DiscountProvidedForIssuanceOfOrdinaryShares`	-	USD	Annual
Discount provided on sale of ordinary shares for business combination	`DiscountProvidedForIssuanceOfOrdinaryShares`	-	USD	Annual
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$22.11M	USD	Annual
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$2.21M	USD	Annual
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$29.09M	USD	Annual
Purchase of in-process research and development included in accounts payable	`PurchaseofInprocessanddevelopmentIncludedinAccountsPayable`	-	USD	Annual
Purchase of in-process research and development included in accounts payable	`PurchaseofInprocessanddevelopmentIncludedinAccountsPayable`	$19.00M	USD	Annual
Purchase of in-process research and development included in accounts payable	`PurchaseofInprocessanddevelopmentIncludedinAccountsPayable`	-	USD	Annual
Changes in operating assets and liabilities adjusted through accumulated deficit	`AdjustmentstoChangesinOperatingAssetsandLiabilities`	-	USD	Annual
Changes in operating assets and liabilities adjusted through accumulated deficit	`AdjustmentstoChangesinOperatingAssetsandLiabilities`	-	USD	Annual
Changes in operating assets and liabilities adjusted through accumulated deficit	`AdjustmentstoChangesinOperatingAssetsandLiabilities`	$2.29M	USD	Annual

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$352.91M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	801.34M	shares	Point-in-time
Issuance of ordinary shares	`StockIssuedDuringPeriodValueNewIssues`	$149.93M	USD	Annual
Discount on the sale of ordinary shares	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$23.61M	USD	Annual
Contributions from shareholders	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$14.53M	USD	Annual
Contributions from shareholders	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$4.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$134.15M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$42.86M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$87.13M	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$29.66M	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.63M	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$47.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-9.87M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$555.00K	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.66M	USD	Annual
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-144.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-674.03M	USD	Annual
Net loss	`ProfitLoss`	$-387.89M	USD	1 Quarter
Net loss	`ProfitLoss`	$-93.30M	USD	Annual
Net loss	`ProfitLoss`	$-950.58M	USD	Annual
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-266.71M	USD	1 Quarter
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$352.91M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	801.34M	shares	Point-in-time

Comprehensive Income 26 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-144.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-674.03M	USD	Annual
Net loss	`ProfitLoss`	$-387.89M	USD	1 Quarter
Net loss	`ProfitLoss`	$-93.30M	USD	Annual
Net loss	`ProfitLoss`	$-950.58M	USD	Annual
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-266.71M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-478.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-9.42M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$851.00K	USD	Annual
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-296.00K	USD	Annual
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-448.00K	USD	Annual
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$2.13M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-92.74M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-672.38M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-960.45M	USD	Annual
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-2.29M	USD	Annual
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-352.00K	USD	Annual
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-105.00K	USD	Annual
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-92.64M	USD	Annual
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-958.15M	USD	Annual
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-672.03M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.